West Announces First Quarter 2016 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/13/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Super Micro Computer establishes $1.25 billion stock sale agreement
- Wall Street ends higher as SpaceX's market debut dominates
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- SpaceX Shares Indicated To Open At $155
West Pharma (WST) Tops Q1 EPS by 2c; Boosts Lower-End of FY16 Outlook
April 28, 2016 9:38 AM EDTWest Pharma (NYSE: WST) reported Q1 EPS of $0.53, $0.02 better than the analyst estimate of $0.51. Revenue for the quarter came in at $362.1 million versus the consensus estimate of $355.86 million.
GUIDANCE:
West Pharma sees FY2016 EPS of $2.12-$2.25, versus prior guidance of... More
